awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30358639-CCE5C1BE-6D56-4F06-8386-D41CA11CC9EC
Q30358639-CCE5C1BE-6D56-4F06-8386-D41CA11CC9EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30358639-CCE5C1BE-6D56-4F06-8386-D41CA11CC9EC
Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.
P2860
Q30358639-CCE5C1BE-6D56-4F06-8386-D41CA11CC9EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30358639-CCE5C1BE-6D56-4F06-8386-D41CA11CC9EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0651dd38d2619b517e7000d1577e6a50bfd4a644
P2860
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.